Infectious Diseases
2022 Activity indicators
- 3 H2020 projects: IMI-COMBACTE-NET and Eranet TRASNCAN (SCRATCH), EDCTP
- 12 national competitive public projects - ISCIII.
- 12 private led projects.
- 91 clinical led studies.
- 11 competitive HR contracts.
- 87 publications.
- IF: 800.64
- Publications in D1: 19 (22 %).
- Publications in Q1: 46 (53 %).
- 2 supervised read thesis.
- 5 consensus documents.
- 1 technical document: GESIDA/SEMFYC
- Project evaluators for national institutions: 10 PIs
- Project evaluators for international institutions: 5 PIs
- Members of editorial committees: 7 PIs
- 1 European patent application (21382486.5.) "Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2".
Milestones
-
Success in the AES 2022 and MICINN call for proposals with two health research projects (PI22/01370; PI22/01878); 2 competitive research contracts; 1 Rio Hortega (CM22/00069), 1 PFIS predoctoral contract (FI22/00111) & 1 postdoctoral contract (JR22/00008).
-
Award of a MARIE SKŁODOWSKA-CURIE contract of excellence (MSCA-IF- 101064842) of the Horizon Europe program to the postdoctoral researcher Elena Moreno del Olmo and mentored by Dr. Sergio Serrano for the development of the project "MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization and clinical exploitation".
-
Participation in several consensus documents, care protocols, technical documents of which we highlight: 1) Consensus document of GeSIDA/National Plan on AIDS regarding antiretroviral treatment in adults infected by the human immunodeficiency virus (MICINN & GESIDA); 2) Shared management of patients with HIV infection between primary care and hospital (GESIDA & semFYC).
-
Martínez-Sanz J, Serrano-Villar S, Muriel A, García Fraile LJ, Orviz E, Mena de Cea Á, Campins AA, Moreno S. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study. Clin Infect Dis. 2023; 76(3):e652-e660. doi: 10.1093/cid/ciac621. PMID: 35903910.
-
Crespillo-Andújar C, Comeche B, Hamer DH, Arevalo-Rodriguez I, Alvarez-Díaz N, Zamora J, Pérez-Molina JA. Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis. PLoS Negl Trop Dis. 2022; 16(5):e0010386. doi: 10.1371/journal.pntd.0010386. PMID: 35576215.
Bibliometrics
Article | Accum. FI | Mean FI | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % on D1 | |
---|---|---|---|---|---|---|---|
2018 | 99 | 441,46 | 4,65 | 74 | 75 | 27 | 27 |
2019 | 105 | 371,58 | 3,91 | 67 | 64 | 21 | 20 |
2020 | 112 | 638,63 | 5,70 | 82 | 73 | 36 | 32 |
2021 | 100 | 673,17 | 6,73 | 76 | 76 | 26 | 26 |
2022 | 87 | 800,64 | 9,20 | 64 | 74 | 19 | 22 |
503 | 2925,5 | 6,04 | 363 | 72 | 129 | 26 |
* Only original articles, editorials, guidelines & reviews